Trial Profile
An open, randomised, multicentre trial of Tomudex (ZD1694) versus 5-Fluorouracil (5-FU) and Leucovorin (LV) in patients with advanced colorectal carcinoma
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 01 Mar 2016
Price :
$35
*
At a glance
- Drugs Raltitrexed (Primary) ; Fluorouracil; Folinic acid
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors AstraZeneca Pharmaceuticals
- 08 Aug 2009 Actual end date (31 Dec 2001), actual initiation date (1 Jan 2000), trial locations (England, Scotland) and lead trial centres added as reported by ISRCTN: Current Controlled Trials.
- 08 Aug 2009 Status changed from not stated to completed as reported by ISRCTN: Current Controlled Trials.
- 19 Feb 2006 New trial record.